SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as retail investors rally around a potential short squeeze, citing high short interest and speculative rumors of a take-private buyout. The community is actively discussing the company's valuation gap compared to industry peers and recent leadership changes, while many express strong sentiment to hold for a reversal.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to reports that the company is suing the U.S. Department of Defense to challenge its inclusion on a military-linked blacklist, sparking significant concern regarding geopolitical risks and ongoing U.S.-China tensions. Investors are actively debating the stock's long-term viability, with many frustrated by its persistent downward trend and questioning whether the current depressed valuation presents a genuine buying opportunity or a permanent value trap.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing heavy retail and institutional activity as the stock experiences significant downward volatility, with the community actively debating whether current price levels represent a generational buying opportunity or a deeper structural correction. Investors are focused on recent AI partnership news as a potential long-term catalyst while monitoring technical support levels amidst broader sector-wide selling pressure.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending as GameStop's CEO Ryan Cohen aggressively pursues a high-profile takeover bid, fueling intense debate across retail investor communities about potential acquisition outcomes and corporate governance. Investors are actively scrutinizing Cohen's strategic vision for eBay while simultaneously tracking GameStop's significant equity exposure and the potential for a larger corporate restructuring.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is currently the focus of intense debate following a post-IPO earnings release that sparked volatility as the market weighs the company's aggressive growth projections and high-profile partnerships against shrinking margins and valuation concerns. Community discussion is sharply divided between believers in the company's unique chip architecture and skeptics who are closely monitoring upcoming insider lockup expirations and the sustainability of its current revenue multiples.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm, through its storage cloud platform, provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng and Brian Wilson in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is trending after securing a multi-year, $335 million storage contract with CoreWeave, a major development that investors view as a transformative revenue catalyst for the company. While the community is actively debating the potential for a share offering to fund future growth, sentiment is heavily influenced by the deal's ability to validate the company as a key player in the AI cloud infrastructure sector.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme downward pressure as short interest rises and investors lose confidence, with the community actively debating whether the stock is a deep-value turnaround opportunity or a sinking ship headed for further lows. Much of the conversation centers on the lack of major partnership catalysts, such as a rumored OpenAI deal, and frustration toward management as the stock continues to underperform the broader software sector.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning, Inc. (GLW) is trending as investors capitalize on its role as a critical provider of optical fiber and glass technology for the expanding AI data center infrastructure. The stock is seeing significant momentum following multi-billion-dollar supply agreements with hyperscalers and key partnerships with industry leaders, fueling community debate about whether it is an underrated play on the ongoing AI infrastructure buildout.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors brace for the company's quarterly earnings report, which serves as a major litmus test for the sustainability of the AI-driven semiconductor rally. Market sentiment is highly divided, with bulls pointing to the company's long-term contracts and fundamental demand, while bears emphasize valuation concerns and potential volatility following the recent sharp pullback in the chip sector.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors anticipate a major catalyst from its expected inclusion in the Russell 1000 index, which many believe will trigger significant institutional buying pressure. The community is actively debating the potential for a short squeeze and discussing recent executive commentary regarding global expansion and future partnership announcements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Phio Pharmaceuticals Corp. (Nasdaq: $PHIO) presents at the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences (OTC Markets Group) and Zacks Small Cap Research, at 3:00 PM ET on Thursday, June 25, 2026. 
 
The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/vic-june-25th-life-sciences-virtual-investor-forum 
 
Phio Pharmaceuticals is a B2i Digital Featured Company. See the company&#39;s profile at https://b2idigital.com/phio-pharmaceuticals 
 
To register and view the presentation: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5389925/phio-pharmaceuticals-corp-nasdaq-phio?utm_source=b2i&amp;utm_medium=marketing&amp;utm_campaign=0624LifeSciencesForumVIC 
 
Request a one-on-one meeting: https://app.axleaccess.com/public/events/636943bb-55cb-4a39-81b5-f658175de392?token=7b91921e-7b44-4da7-be93-ea5c37a5ed76 
 
Robert Bitterman, President and CEO, presents for Phio Pharmaceuticals. He has chaired the company&#39;s board since 2012 and has led as President and CEO since 2023, with prior chief executive roles at Cutanea Life Sciences and Isolagen. 
 
Phio Pharmaceuticals is developing therapeutics using INTASYL, a chemically modified siRNA technology designed to silence specific genes that hinder the immune system&#39;s ability to fight cancer, with a focus on immuno-oncology. Unlike many siRNA approaches that rely on complex delivery systems such as lipid nanoparticles, INTASYL compounds are engineered to self-deliver into cells without additional formulations, simplifying administration and potentially reducing toxicity. 
 
Learn more at https://phiopharma.com/investors/. 
 
Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at www.virtualinvestorconferences.com. 
 
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com. 
 
B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.

David Shapiro

top moon

Dwight

Edward

Alfredo

Bonnie Siegmund

Ariana Storck

Craig Salinas

Michael Musto

Roberta Creech

Henry Callaghan

John Park

Melissa Vermillion

Shirley Hall

Jeanne Hodges

James Adair

Micheal Fikes

Kelly Distaffen

Nina Studdard

Renee Blankenship

Filomena Marsh

Raymond Oliver

Terry Skora

Lucy Pena

Amber Reilly

Edwina Packard

Karen Paris

Lillian Ellis

Ella Costello

Joseph Weiler

Explore the Life Sciences Virtual Investor Forum by Virtual Investor Conferences, featuring online presentations from public life science companies for global retail and institutional investors.

B2idigital

VIC Life Sciences Virtual Investor Forum | B2i Digital Featured Conference

Phio Pharmaceuticals Corp (NASDAQ CM: PHIO) a Featured Profile on B2i Digital

Phio Pharmaceuticals Corp (Nasdaq: PHIO) Profile on B2i Digital

Phio Pharmaceuticals Corp. (NASDAQ: PHIO)

Virtualinvestorconferences

Axleaccess

Axle

Phio Pharmaceuticals

Investors - Phio Pharmaceuticals

Each conference features live investor presentations from top executives for stockholders, potential investors, and financial analysts.

Virtual Investor Conferences

b2i digital - connecting companies and investors through digital marketing, investor conferences, and direct introductions and meetings.

B2i Digital - Connecting companies and investors

StockTwits Web

Phio Pharmaceuticals Corp

) presents at the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences (OTC Markets Group) and Zacks Small Cap Research, at 3:00 PM ET on Thursday, June 25, 2026. 
 
The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: 

 
 
Phio Pharmaceuticals is a B2i Digital Featured Company. See the company's profile at 

 
 
To register and view the presentation: 

 
 
Robert Bitterman, President and CEO, presents for Phio Pharmaceuticals. He has chaired the company's board since 2012 and has led as President and CEO since 2023, with prior chief executive roles at Cutanea Life Sciences and Isolagen. 
 
Phio Pharmaceuticals is developing therapeutics using INTASYL, a chemically modified siRNA technology designed to silence specific genes that hinder the immune system's ability to fight cancer, with a focus on immuno-oncology. Unlike many siRNA approaches that rely on complex delivery systems such as lipid nanoparticles, INTASYL compounds are engineered to self-deliver into cells without additional formulations, simplifying administration and potentially reducing toxicity. 
 
Learn more at 

. 
 
Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at 

. 
 
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at 

. 
 
B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.

Phio Pharmaceuticals is advancing immuno-oncology through its INTASYL siRNA platform, designed to simplify delivery while targeting cancer-related immune suppression pathways. 
 
See Phio Pharmaceuticals’ Featured Company profile: 
https://b2idigital.com/phio-pharmaceuticals 
 
Learn more about the B2i Digital Featured Conference: 
https://b2idigital.com/vic-june-25th-life-sciences-virtual-investor-forum

Phio Pharmaceuticals is advancing immuno-oncology through its INTASYL siRNA platform, designed to simplify delivery while targeting cancer-related immune suppression pathways. 
 
See Phio Pharmaceuticals’ Featured Company profile: 


 
 
Learn more about the B2i Digital Featured Conference: 
